APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Cisplatin Injection

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Cisplatin Injection Industry Growth and Trends Forecast to 2032

Report ID 173978320120 December 2025106 pages

Choose your research edition.

Industry ResearchCisplatin Injection Industry Research Report 2026128 pages · $2,950 USDIndustry Growth & TrendsGlobal Cisplatin Injection Industry Growth and Trends Forecast to 2032106 pages · $3,450 USDMarket StructureGlobal Cisplatin Injection Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032199 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Cisplatin Injection Market Outlook and Growth Opportunities 2026198 pages · $4,250 USDMarket Analysis & ForecastGlobal Cisplatin Injection Market Analysis and Forecast 2026-2032192 pages · $4,950 USD

Market perspective

The global Cisplatin Injection market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Cisplatin Injection is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Cisplatin Injection is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Cisplatin Injection is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Cisplatin Injection include Cipla, Hospira(Pfizer), Taj Pharmaceuticals, Fresenius Kabi, Lingnan Pharmacy, Hansoh Pharma, Jinzhou Jiutai Pharmaceutical, Nanjing Pharmaceutical Factory and Qilu Pharmaceutical, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Cisplatin Injection market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Cisplatin Injection market size, estimates, and forecasts are presented in terms of sales volume (Tons) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Cisplatin Injection market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Cisplatin Injection.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Cisplatin Injection market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Cisplatin Injection Market by Company

Cipla

Hospira(Pfizer)

Taj Pharmaceuticals

Fresenius Kabi

Lingnan Pharmacy

Hansoh Pharma

Jinzhou Jiutai Pharmaceutical

Nanjing Pharmaceutical Factory

Qilu Pharmaceutical

Luoxin

Teva

Bievalley

Yunnan Phytopharmaceutical

Cisplatin Injection Segment by Type

50ml

100ml

200ml

Cisplatin Injection Segment by Application

NSCLC

Testicular Cancer

Ovarian Cancer

Other

Cisplatin Injection Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Cisplatin Injection market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Cisplatin Injection and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Cisplatin Injection.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Cisplatin Injection manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Cisplatin Injection in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of 50ml Table 2. Major Company of 100ml Table 3. Major Company of 200ml Table 4. Global Cisplatin Injection Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 5. Global Cisplatin Injection Sales by Type (2021-2026) & (Tons) Table 6. Global Cisplatin Injection Sales Market Share in Volume by Type (2021-2026) Table 7. Global Cisplatin Injection Sales by Type (2021-2026) & (US$ Million) Table 8. Global Cisplatin Injection Sales Market Share in Value by Type (2021-2026) Table 9. Global Cisplatin Injection Price by Type (2021-2026) & (US$/Kg) Table 10. Global Cisplatin Injection Sales by Type (2027-2032) & (Tons) Table 11. Global Cisplatin Injection Sales Market Share in Volume by Type (2027-2032) Table 12. Global Cisplatin Injection Sales by Type (2027-2032) & (US$ Million) Table 13. Global Cisplatin Injection Sales Market Share in Value by Type (2027-2032) Table 14. Global Cisplatin Injection Price by Type (2027-2032) & (US$/Kg) Table 15. North America Cisplatin Injection Sales by Type (2021-2026) & (Tons) Table 16. North America Cisplatin Injection Sales by Type (2021-2026) & (US$ Million) Table 17. Europe Cisplatin Injection Sales by Type (2021-2026) & (Tons) Table 18. Europe Cisplatin Injection Sales by Type (2021-2026) & (US$ Million) Table 19. Asia-Pacific Cisplatin Injection Sales by Type (2021-2026) & (Tons) Table 20. Asia-Pacific Cisplatin Injection Sales by Type (2021-2026) & (US$ Million) Table 21. Latin America Cisplatin Injection Sales by Type (2021-2026) & (Tons) Table 22. Latin America Cisplatin Injection Sales by Type (2021-2026) & (US$ Million) Table 23. Middle East and Africa Cisplatin Injection Sales by Type (2021-2026) & (Tons) Table 24. Middle East and Africa Cisplatin Injection Sales by Type (2021-2026) & (US$ Million) Table 25. Cisplatin Injection Industry Trends Table 26. Cisplatin Injection Industry Drivers Table 27. Cisplatin Injection Industry Opportunities and Challenges Table 28. Cisplatin Injection Industry Restraints Table 29. Global Cisplatin Injection Sales Revenue by Company (US$ Million) & (2021-2026) Table 30. Global Cisplatin Injection Revenue Market Share by Company (2021-2026) Table 31. Global Cisplatin Injection Sales by Company (2021-2026) & (Tons) Table 32. Global Cisplatin Injection Sales Share by Company (2021-2026) Table 33. Global Cisplatin Injection Market Price by Company (2021-2026) & (US$/Kg) Table 34. Global Cisplatin Injection Industry Company Ranking, 2024 VS 2025 VS 2026 Table 35. Global Cisplatin Injection Major Company Production Sites and Headquarters Table 36. Global Cisplatin Injection Company, Product Type & Application Table 37. Global Cisplatin Injection Company Establishment Date Table 38. Global Company Market Concentration Ratio (CR5 and HHI) Table 39. Global Cisplatin Injection by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 40. Global Cisplatin Injection Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 41. Global Cisplatin Injection Sales by Region (2021-2026) & (Tons) Table 42. Global Cisplatin Injection Sales Market Share in Volume by Region (2021-2026) Table 43. Global Cisplatin Injection Sales by Region (2021-2026) & (US$ Million) Table 44. Global Cisplatin Injection Sales Market Share in Value by Region (2021-2026) Table 45. Global Cisplatin Injection Sales (Tons), Value (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 46. Global Cisplatin Injection Sales by Region (2027-2032) & (Tons) Table 47. Global Cisplatin Injection Sales Market Share in Volume by Region (2027-2032) Table 48. Global Cisplatin Injection Sales by Region (2027-2032) & (US$ Million) Table 49. Global Cisplatin Injection Sales Market Share in Value by Region (2027-2032) Table 50. Global Cisplatin Injection Sales (Tons), Value (US$ Million), Price (US$/Kg) and Gross Margin (2027-2032) Table 51. Global Cisplatin Injection Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 52. Global Cisplatin Injection Sales by Application (2021-2026) & (Tons) Table 53. Global Cisplatin Injection Sales Market Share in Volume by Application (2021-2026) Table 54. Global Cisplatin Injection Sales by Application (2021-2026) & (US$ Million) Table 55. Global Cisplatin Injection Sales Market Share in Value by Application (2021-2026) Table 56. Global Cisplatin Injection Price by Application (2021-2026) & (US$/Kg) Table 57. Global Cisplatin Injection Sales by Application (2027-2032) & (Tons) Table 58. Global Cisplatin Injection Sales Market Share in Volume by Application (2027-2032) Table 59. Global Cisplatin Injection Sales by Application (2027-2032) & (US$ Million) Table 60. Global Cisplatin Injection Sales Market Share in Value by Application (2027-2032) Table 61. Global Cisplatin Injection Price by Application (2027-2032) & (US$/Kg) Table 62. North America Cisplatin Injection Sales by Application (2021-2026) & (Tons) Table 63. North America Cisplatin Injection Sales by Application (2021-2026) & (US$ Million) Table 64. Europe Cisplatin Injection Sales by Application (2021-2026) & (Tons) Table 65. Europe Cisplatin Injection Sales by Application (2021-2026) & (US$ Million) Table 66. Asia-Pacific Cisplatin Injection Sales by Application (2021-2026) & (Tons) Table 67. Asia-Pacific Cisplatin Injection Sales by Application (2021-2026) & (US$ Million) Table 68. Latin America Cisplatin Injection Sales by Application (2021-2026) & (Tons) Table 69. Latin America Cisplatin Injection Sales by Application (2021-2026) & (US$ Million) Table 70. Middle East and Africa Cisplatin Injection Sales by Application (2021-2026) & (Tons) Table 71. Middle East and Africa Cisplatin Injection Sales by Application (2021-2026) & (US$ Million) Table 72. Cipla Company Information Table 73. Cipla Business Overview Table 74. Cipla Cisplatin Injection Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 75. Cipla Cisplatin Injection Product Portfolio Table 76. Cipla Recent Development Table 77. Hospira(Pfizer) Company Information Table 78. Hospira(Pfizer) Business Overview Table 79. Hospira(Pfizer) Cisplatin Injection Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 80. Hospira(Pfizer) Cisplatin Injection Product Portfolio Table 81. Hospira(Pfizer) Recent Development Table 82. Taj Pharmaceuticals Company Information Table 83. Taj Pharmaceuticals Business Overview Table 84. Taj Pharmaceuticals Cisplatin Injection Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 85. Taj Pharmaceuticals Cisplatin Injection Product Portfolio Table 86. Taj Pharmaceuticals Recent Development Table 87. Fresenius Kabi Company Information Table 88. Fresenius Kabi Business Overview Table 89. Fresenius Kabi Cisplatin Injection Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 90. Fresenius Kabi Cisplatin Injection Product Portfolio Table 91. Fresenius Kabi Recent Development Table 92. Lingnan Pharmacy Company Information Table 93. Lingnan Pharmacy Business Overview Table 94. Lingnan Pharmacy Cisplatin Injection Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 95. Lingnan Pharmacy Cisplatin Injection Product Portfolio Table 96. Lingnan Pharmacy Recent Development Table 97. Hansoh Pharma Company Information Table 98. Hansoh Pharma Business Overview Table 99. Hansoh Pharma Cisplatin Injection Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 100. Hansoh Pharma Cisplatin Injection Product Portfolio Table 101. Hansoh Pharma Recent Development Table 102. Jinzhou Jiutai Pharmaceutical Company Information Table 103. Jinzhou Jiutai Pharmaceutical Business Overview Table 104. Jinzhou Jiutai Pharmaceutical Cisplatin Injection Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 105. Jinzhou Jiutai Pharmaceutical Cisplatin Injection Product Portfolio Table 106. Jinzhou Jiutai Pharmaceutical Recent Development Table 107. Nanjing Pharmaceutical Factory Company Information Table 108. Nanjing Pharmaceutical Factory Business Overview Table 109. Nanjing Pharmaceutical Factory Cisplatin Injection Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 110. Nanjing Pharmaceutical Factory Cisplatin Injection Product Portfolio Table 111. Nanjing Pharmaceutical Factory Recent Development Table 112. Qilu Pharmaceutical Company Information Table 113. Qilu Pharmaceutical Business Overview Table 114. Qilu Pharmaceutical Cisplatin Injection Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 115. Qilu Pharmaceutical Cisplatin Injection Product Portfolio Table 116. Qilu Pharmaceutical Recent Development Table 117. Luoxin Company Information Table 118. Luoxin Business Overview Table 119. Luoxin Cisplatin Injection Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 120. Luoxin Cisplatin Injection Product Portfolio Table 121. Luoxin Recent Development Table 122. Teva Company Information Table 123. Teva Business Overview Table 124. Teva Cisplatin Injection Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 125. Teva Cisplatin Injection Product Portfolio Table 126. Teva Recent Development Table 127. Bievalley Company Information Table 128. Bievalley Business Overview Table 129. Bievalley Cisplatin Injection Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 130. Bievalley Cisplatin Injection Product Portfolio Table 131. Bievalley Recent Development Table 132. Yunnan Phytopharmaceutical Company Information Table 133. Yunnan Phytopharmaceutical Business Overview Table 134. Yunnan Phytopharmaceutical Cisplatin Injection Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 135. Yunnan Phytopharmaceutical Cisplatin Injection Product Portfolio Table 136. Yunnan Phytopharmaceutical Recent Development Table 137. North America Cisplatin Injection Market Size Growth Rate (CAGR) by Country (Tons): 2021 VS 2025 VS 2032 Table 138. North America Cisplatin Injection Sales by Country (2021-2026) & (Tons) Table 139. North America Cisplatin Injection Sales Market Share by Country (2021-2026) Table 140. North America Cisplatin Injection Sales Forecast by Country (2027-2032) & (Tons) Table 141. North America Cisplatin Injection Sales Market Share Forecast by Country (2027-2032) Table 142. North America Cisplatin Injection Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 143. North America Cisplatin Injection Market Size by Country (2021-2026) & (US$ Million) Table 144. North America Cisplatin Injection Market Share by Country (2021-2026) Table 145. North America Cisplatin Injection Market Size Forecast by Country (2027-2032) & (US$ Million) Table 146. North America Cisplatin Injection Market Share Forecast by Country (2027-2032) Table 147. Europe Cisplatin Injection Market Size Growth Rate (CAGR) by Country (Tons): 2021 VS 2025 VS 2032 Table 148. Europe Cisplatin Injection Sales by Country (2021-2026) & (Tons) Table 149. Europe Cisplatin Injection Sales Market Share by Country (2021-2026) Table 150. Europe Cisplatin Injection Sales Forecast by Country (2027-2032) & (Tons) Table 151. Europe Cisplatin Injection Sales Market Share Forecast by Country (2027-2032) Table 152. Europe Cisplatin Injection Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 153. Europe Cisplatin Injection Market Size by Country (2021-2026) & (US$ Million) Table 154. Europe Cisplatin Injection Market Share by Country (2021-2026) Table 155. Europe Cisplatin Injection Market Size Forecast by Country (2027-2032) & (US$ Million) Table 156. Europe Cisplatin Injection Market Share Forecast by Country (2027-2032) Table 157. Asia-Pacific Cisplatin Injection Market Size Growth Rate (CAGR) by Country (Tons): 2021 VS 2025 VS 2032 Table 158. Asia-Pacific Cisplatin Injection Sales by Country (2021-2026) & (Tons) Table 159. Asia-Pacific Cisplatin Injection Sales Market Share by Country (2021-2026) Table 160. Asia-Pacific Cisplatin Injection Sales Forecast by Country (2027-2032) & (Tons) Table 161. Asia-Pacific Cisplatin Injection Sales Market Share Forecast by Country (2027-2032) Table 162. Asia-Pacific Cisplatin Injection Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 163. Asia-Pacific Cisplatin Injection Market Size by Country (2021-2026) & (US$ Million) Table 164. Asia-Pacific Cisplatin Injection Market Share by Country (2021-2026) Table 165. Asia-Pacific Cisplatin Injection Market Size Forecast by Country (2027-2032) & (US$ Million) Table 166. Asia-Pacific Cisplatin Injection Market Share Forecast by Country (2027-2032) Table 167. Latin America Cisplatin Injection Market Size Growth Rate (CAGR) by Country (Tons): 2021 VS 2025 VS 2032 Table 168. Latin America Cisplatin Injection Sales by Country (2021-2026) & (Tons) Table 169. Latin America Cisplatin Injection Sales Market Share by Country (2021-2026) Table 170. Latin America Cisplatin Injection Sales Forecast by Country (2027-2032) & (Tons) Table 171. Latin America Cisplatin Injection Sales Market Share Forecast by Country (2027-2032) Table 172. Latin America Cisplatin Injection Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 173. Latin America Cisplatin Injection Market Size by Country (2021-2026) & (US$ Million) Table 174. Latin America Cisplatin Injection Market Share by Country (2021-2026) Table 175. Latin America Cisplatin Injection Market Size Forecast by Country (2027-2032) & (US$ Million) Table 176. Latin America Cisplatin Injection Market Share Forecast by Country (2027-2032) Table 177. Middle East and Africa Cisplatin Injection Market Size Growth Rate (CAGR) by Country (Tons): 2021 VS 2025 VS 2032 Table 178. Middle East and Africa Cisplatin Injection Sales by Country (2021-2026) & (Tons) Table 179. Middle East and Africa Cisplatin Injection Sales Market Share by Country (2021-2026) Table 180. Middle East and Africa Cisplatin Injection Sales Forecast by Country (2027-2032) & (Tons) Table 181. Middle East and Africa Cisplatin Injection Sales Market Share Forecast by Country (2027-2032) Table 182. Middle East and Africa Cisplatin Injection Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 183. Middle East and Africa Cisplatin Injection Market Size by Country (2021-2026) & (US$ Million) Table 184. Middle East and Africa Cisplatin Injection Market Share by Country (2021-2026) Table 185. Middle East and Africa Cisplatin Injection Market Size Forecast by Country (2027-2032) & (US$ Million) Table 186. Middle East and Africa Cisplatin Injection Market Share Forecast by Country (2027-2032) Table 187. Key Raw Materials Table 188. Raw Materials Key Suppliers Table 189. Cisplatin Injection Distributors List Table 190. Cisplatin Injection Customers List Table 191. Research Programs/Design for This Report Table 192. Authors List of This Report Table 193. Secondary Sources Table 194. Primary Sources List of Figures Figure 1. Cisplatin Injection Image Figure 2. Global Cisplatin Injection Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Cisplatin Injection Market Size (2021-2032) & (US$ Million) Figure 4. Global Cisplatin Injection Sales (2021-2032) & (Tons) Figure 5. 50ml Image Figure 6. Global 50ml Sales YoY Growth (2021-2032) & (Tons) Figure 7. 100ml Image Figure 8. Global 100ml Sales YoY Growth (2021-2032) & (Tons) Figure 9. 200ml Image Figure 10. Global 200ml Sales YoY Growth (2021-2032) & (Tons) Figure 11. Global Cisplatin Injection Market Size Overview by Type (2021-2032) & (US$ Million) Figure 12. Global Cisplatin Injection Market Share by Type 2025 VS 2032 Figure 13. North America Cisplatin Injection Sales Market Share in Volume by Type in 2025 Figure 14. North America Cisplatin Injection Sales Market Share in Value by Type in 2025 Figure 15. Europe Cisplatin Injection Sales Market Share in Volume by Type in 2025 Figure 16. Europe Cisplatin Injection Sales Market Share in Value by Type in 2025 Figure 17. Asia-Pacific Cisplatin Injection Sales Market Share in Volume by Type in 2025 Figure 18. Asia-Pacific Cisplatin Injection Sales Market Share in Value by Type in 2025 Figure 19. Latin America Cisplatin Injection Sales Market Share in Volume by Type in 2025 Figure 20. Latin America Cisplatin Injection Sales Market Share in Value by Type in 2025 Figure 21. Middle East and Africa Cisplatin Injection Sales Market Share in Volume by Type in 2025 Figure 22. Middle East and Africa Cisplatin Injection Sales Market Share in Value by Type in 2025 Figure 23. Global Top 5 and 10 Cisplatin Injection Players Market Share by Revenue in 2025 Figure 24. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 25. NSCLC Image Figure 26. Global NSCLC Sales YoY Growth (2021-2032) & (Tons) Figure 27. Testicular Cancer Image Figure 28. Global Testicular Cancer Sales YoY Growth (2021-2032) & (Tons) Figure 29. Ovarian Cancer Image Figure 30. Global Ovarian Cancer Sales YoY Growth (2021-2032) & (Tons) Figure 31. Other Image Figure 32. Global Other Sales YoY Growth (2021-2032) & (Tons) Figure 33. Global Cisplatin Injection Market Size Overview by Application (2021-2032) & (US$ Million) Figure 34. Global Cisplatin Injection Market Share by Application 2025 VS 2032 Figure 35. North America Cisplatin Injection Sales Market Share in Volume by Application in 2025 Figure 36. North America Cisplatin Injection Sales Market Share in Value by Application in 2025 Figure 37. Europe Cisplatin Injection Sales Market Share in Volume by Application in 2025 Figure 38. Europe Cisplatin Injection Sales Market Share in Value by Application in 2025 Figure 39. Asia-Pacific Cisplatin Injection Sales Market Share in Volume by Application in 2025 Figure 40. Asia-Pacific Cisplatin Injection Sales Market Share in Value by Application in 2025 Figure 41. Latin America Cisplatin Injection Sales Market Share in Volume by Application in 2025 Figure 42. Latin America Cisplatin Injection Sales Market Share in Value by Application in 2025 Figure 43. Middle East and Africa Cisplatin Injection Sales Market Share in Volume by Application in 2025 Figure 44. Middle East and Africa Cisplatin Injection Sales Market Share in Value by Application in 2025 Figure 45. North America Cisplatin Injection Sales by Country: 2021 VS 2025 VS 2032 (Tons) Figure 46. North America Cisplatin Injection Sales Share by Country: 2021 VS 2025 VS 2032 Figure 47. North America Cisplatin Injection Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 48. North America Cisplatin Injection Market Share by Country: 2021 VS 2025 VS 2032 Figure 49. Europe Cisplatin Injection Sales by Country: 2021 VS 2025 VS 2032 (Tons) Figure 50. Europe Cisplatin Injection Sales Share by Country: 2021 VS 2025 VS 2032 Figure 51. Europe Cisplatin Injection Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 52. Europe Cisplatin Injection Market Share by Country: 2021 VS 2025 VS 2032 Figure 53. Asia-Pacific Cisplatin Injection Sales by Country: 2021 VS 2025 VS 2032 (Tons) Figure 54. Asia-Pacific Cisplatin Injection Sales Share by Country: 2021 VS 2025 VS 2032 Figure 55. Asia-Pacific Cisplatin Injection Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Asia-Pacific Cisplatin Injection Market Share by Country: 2021 VS 2025 VS 2032 Figure 57. Latin America Cisplatin Injection Sales by Country: 2021 VS 2025 VS 2032 (Tons) Figure 58. Latin America Cisplatin Injection Sales Share by Country: 2021 VS 2025 VS 2032 Figure 59. Latin America Cisplatin Injection Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Latin America Cisplatin Injection Market Share by Country: 2021 VS 2025 VS 2032 Figure 61. Middle East and Africa Cisplatin Injection Sales by Country: 2021 VS 2025 VS 2032 (Tons) Figure 62. Middle East and Africa Cisplatin Injection Sales Share by Country: 2021 VS 2025 VS 2032 Figure 63. Middle East and Africa Cisplatin Injection Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 64. Middle East and Africa Cisplatin Injection Market Share by Country: 2021 VS 2025 VS 2032 Figure 65. Cisplatin Injection Value Chain Figure 66. Key Raw Materials Price Figure 67. Manufacturing Cost Structure Figure 68. Cisplatin Injection Production Mode & Process Figure 69. Direct Comparison with Distribution Share Figure 70. Distributors Profiles Figure 71. Years Considered Figure 72. Research Process Figure 73. Key Executives Interviewed

Scope & coverage.

Types
  • 50ml
  • 100ml
  • 200ml
Applications
  • NSCLC
  • Testicular Cancer
  • Ovarian Cancer
  • Other
Companies covered
  • Cipla
  • Hospira(Pfizer)
  • Taj Pharmaceuticals
  • Fresenius Kabi
  • Lingnan Pharmacy
  • Hansoh Pharma
  • Jinzhou Jiutai Pharmaceutical
  • Nanjing Pharmaceutical Factory
  • Qilu Pharmaceutical
  • Luoxin
  • Teva
  • Bievalley
  • Yunnan Phytopharmaceutical

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Cisplatin Injection Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Cisplatin Injection Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Cisplatin Injection Market by Type
  6. 1.3.1 50ml
  7. 1.3.2 100ml
  8. 1.3.3 200ml
  9. 1.4 Global Cisplatin Injection Market Size by Type
  10. 1.4.1 Global Cisplatin Injection Market Size Overview by Type (2021-2032)
  11. 1.4.2 Global Cisplatin Injection Historic Market Size Review by Type (2021-2026)
  12. 1.4.3 Global Cisplatin Injection Forecasted Market Size by Type (2027-2032)
  13. 1.5 Key Regions Market Size by Type
  14. 1.5.1 North America Cisplatin Injection Sales Breakdown by Type (2021-2026)
  15. 1.5.2 Europe Cisplatin Injection Sales Breakdown by Type (2021-2026)
  16. 1.5.3 Asia-Pacific Cisplatin Injection Sales Breakdown by Type (2021-2026)
  17. 1.5.4 South America Cisplatin Injection Sales Breakdown by Type (2021-2026)
  18. 1.5.5 Middle East and Africa Cisplatin Injection Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Cisplatin Injection Industry Trends
  2. 2.2 Cisplatin Injection Industry Drivers
  3. 2.3 Cisplatin Injection Industry Opportunities and Challenges
  4. 2.4 Cisplatin Injection Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Cisplatin Injection Revenue (2021-2026)
  2. 3.2 Global Top Players by Cisplatin Injection Sales (2021-2026)
  3. 3.3 Global Top Players by Cisplatin Injection Price (2021-2026)
  4. 3.4 Global Cisplatin Injection Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Cisplatin Injection Major Company Production Sites & Headquarters
  6. 3.6 Global Cisplatin Injection Company, Product Type & Application
  7. 3.7 Global Cisplatin Injection Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Cisplatin Injection Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Cisplatin Injection Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Cisplatin Injection Tier 1, Tier 2, and Tier 3
4 Cisplatin Injection Regional Status and Outlook
  1. 4.1 Global Cisplatin Injection Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Cisplatin Injection Historic Market Size by Region
  3. 4.2.1 Global Cisplatin Injection Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Cisplatin Injection Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Cisplatin Injection Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Cisplatin Injection Forecasted Market Size by Region
  7. 4.3.1 Global Cisplatin Injection Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Cisplatin Injection Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Cisplatin Injection Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Cisplatin Injection by Application
  1. 5.1 Cisplatin Injection Market by Application
  2. 5.1.1 NSCLC
  3. 5.1.2 Testicular Cancer
  4. 5.1.3 Ovarian Cancer
  5. 5.1.4 Other
  6. 5.2 Global Cisplatin Injection Market Size by Application
  7. 5.2.1 Global Cisplatin Injection Market Size Overview by Application (2021-2032)
  8. 5.2.2 Global Cisplatin Injection Historic Market Size Review by Application (2021-2026)
  9. 5.2.3 Global Cisplatin Injection Forecasted Market Size by Application (2027-2032)
  10. 5.3 Key Regions Market Size by Application
  11. 5.3.1 North America Cisplatin Injection Sales Breakdown by Application (2021-2026)
  12. 5.3.2 Europe Cisplatin Injection Sales Breakdown by Application (2021-2026)
  13. 5.3.3 Asia-Pacific Cisplatin Injection Sales Breakdown by Application (2021-2026)
  14. 5.3.4 South America Cisplatin Injection Sales Breakdown by Application (2021-2026)
  15. 5.3.5 Middle East and Africa Cisplatin Injection Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Cipla
  2. 6.1.1 Cipla Company Information
  3. 6.1.2 Cipla Business Overview
  4. 6.1.3 Cipla Cisplatin Injection Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Cipla Cisplatin Injection Product Portfolio
  6. 6.1.5 Cipla Recent Developments
  7. 6.2 Hospira(Pfizer)
  8. 6.2.1 Hospira(Pfizer) Company Information
  9. 6.2.2 Hospira(Pfizer) Business Overview
  10. 6.2.3 Hospira(Pfizer) Cisplatin Injection Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Hospira(Pfizer) Cisplatin Injection Product Portfolio
  12. 6.2.5 Hospira(Pfizer) Recent Developments
  13. 6.3 Taj Pharmaceuticals
  14. 6.3.1 Taj Pharmaceuticals Company Information
  15. 6.3.2 Taj Pharmaceuticals Business Overview
  16. 6.3.3 Taj Pharmaceuticals Cisplatin Injection Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Taj Pharmaceuticals Cisplatin Injection Product Portfolio
  18. 6.3.5 Taj Pharmaceuticals Recent Developments
  19. 6.4 Fresenius Kabi
  20. 6.4.1 Fresenius Kabi Company Information
  21. 6.4.2 Fresenius Kabi Business Overview
  22. 6.4.3 Fresenius Kabi Cisplatin Injection Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Fresenius Kabi Cisplatin Injection Product Portfolio
  24. 6.4.5 Fresenius Kabi Recent Developments
  25. 6.5 Lingnan Pharmacy
  26. 6.5.1 Lingnan Pharmacy Company Information
  27. 6.5.2 Lingnan Pharmacy Business Overview
  28. 6.5.3 Lingnan Pharmacy Cisplatin Injection Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Lingnan Pharmacy Cisplatin Injection Product Portfolio
  30. 6.5.5 Lingnan Pharmacy Recent Developments
  31. 6.6 Hansoh Pharma
  32. 6.6.1 Hansoh Pharma Company Information
  33. 6.6.2 Hansoh Pharma Business Overview
  34. 6.6.3 Hansoh Pharma Cisplatin Injection Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Hansoh Pharma Cisplatin Injection Product Portfolio
  36. 6.6.5 Hansoh Pharma Recent Developments
  37. 6.7 Jinzhou Jiutai Pharmaceutical
  38. 6.7.1 Jinzhou Jiutai Pharmaceutical Company Information
  39. 6.7.2 Jinzhou Jiutai Pharmaceutical Business Overview
  40. 6.7.3 Jinzhou Jiutai Pharmaceutical Cisplatin Injection Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Jinzhou Jiutai Pharmaceutical Cisplatin Injection Product Portfolio
  42. 6.7.5 Jinzhou Jiutai Pharmaceutical Recent Developments
  43. 6.8 Nanjing Pharmaceutical Factory
  44. 6.8.1 Nanjing Pharmaceutical Factory Company Information
  45. 6.8.2 Nanjing Pharmaceutical Factory Business Overview
  46. 6.8.3 Nanjing Pharmaceutical Factory Cisplatin Injection Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Nanjing Pharmaceutical Factory Cisplatin Injection Product Portfolio
  48. 6.8.5 Nanjing Pharmaceutical Factory Recent Developments
  49. 6.9 Qilu Pharmaceutical
  50. 6.9.1 Qilu Pharmaceutical Company Information
  51. 6.9.2 Qilu Pharmaceutical Business Overview
  52. 6.9.3 Qilu Pharmaceutical Cisplatin Injection Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 Qilu Pharmaceutical Cisplatin Injection Product Portfolio
  54. 6.9.5 Qilu Pharmaceutical Recent Developments
  55. 6.10 Luoxin
  56. 6.10.1 Luoxin Company Information
  57. 6.10.2 Luoxin Business Overview
  58. 6.10.3 Luoxin Cisplatin Injection Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 Luoxin Cisplatin Injection Product Portfolio
  60. 6.10.5 Luoxin Recent Developments
  61. 6.11 Teva
  62. 6.11.1 Teva Company Information
  63. 6.11.2 Teva Business Overview
  64. 6.11.3 Teva Cisplatin Injection Sales, Revenue and Gross Margin (2021-2026)
  65. 6.11.4 Teva Cisplatin Injection Product Portfolio
  66. 6.11.5 Teva Recent Developments
  67. 6.12 Bievalley
  68. 6.12.1 Bievalley Company Information
  69. 6.12.2 Bievalley Business Overview
  70. 6.12.3 Bievalley Cisplatin Injection Sales, Revenue and Gross Margin (2021-2026)
  71. 6.12.4 Bievalley Cisplatin Injection Product Portfolio
  72. 6.12.5 Bievalley Recent Developments
  73. 6.13 Yunnan Phytopharmaceutical
  74. 6.13.1 Yunnan Phytopharmaceutical Company Information
  75. 6.13.2 Yunnan Phytopharmaceutical Business Overview
  76. 6.13.3 Yunnan Phytopharmaceutical Cisplatin Injection Sales, Revenue and Gross Margin (2021-2026)
  77. 6.13.4 Yunnan Phytopharmaceutical Cisplatin Injection Product Portfolio
  78. 6.13.5 Yunnan Phytopharmaceutical Recent Developments
7 North America by Country
  1. 7.1 North America Cisplatin Injection Sales by Country
  2. 7.1.1 North America Cisplatin Injection Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Cisplatin Injection Sales by Country (2021-2026)
  4. 7.1.3 North America Cisplatin Injection Sales Forecast by Country (2027-2032)
  5. 7.2 North America Cisplatin Injection Market Size by Country
  6. 7.2.1 North America Cisplatin Injection Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Cisplatin Injection Market Size by Country (2021-2026)
  8. 7.2.3 North America Cisplatin Injection Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Cisplatin Injection Sales by Country
  2. 8.1.1 Europe Cisplatin Injection Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Cisplatin Injection Sales by Country (2021-2026)
  4. 8.1.3 Europe Cisplatin Injection Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Cisplatin Injection Market Size by Country
  6. 8.2.1 Europe Cisplatin Injection Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Cisplatin Injection Market Size by Country (2021-2026)
  8. 8.2.3 Europe Cisplatin Injection Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Cisplatin Injection Sales by Country
  2. 9.1.1 Asia-Pacific Cisplatin Injection Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Cisplatin Injection Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Cisplatin Injection Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Cisplatin Injection Market Size by Country
  6. 9.2.1 Asia-Pacific Cisplatin Injection Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Cisplatin Injection Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Cisplatin Injection Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Cisplatin Injection Sales by Country
  2. 10.1.1 South America Cisplatin Injection Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Cisplatin Injection Sales by Country (2021-2026)
  4. 10.1.3 South America Cisplatin Injection Sales Forecast by Country (2027-2032)
  5. 10.2 South America Cisplatin Injection Market Size by Country
  6. 10.2.1 South America Cisplatin Injection Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Cisplatin Injection Market Size by Country (2021-2026)
  8. 10.2.3 South America Cisplatin Injection Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Cisplatin Injection Sales by Country
  2. 11.1.1 Middle East and Africa Cisplatin Injection Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Cisplatin Injection Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Cisplatin Injection Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Cisplatin Injection Market Size by Country
  6. 11.2.1 Middle East and Africa Cisplatin Injection Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Cisplatin Injection Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Cisplatin Injection Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Cisplatin Injection Value Chain Analysis
  2. 12.1.1 Cisplatin Injection Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Cisplatin Injection Production Mode & Process
  7. 12.2 Cisplatin Injection Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Cisplatin Injection Distributors
  10. 12.2.3 Cisplatin Injection Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst